Sale!

WNT5A Gene Robinow Syndrome Autosomal Dominant Type 1 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The WNT5A gene plays a crucial role in the development of various body structures, including bones and other tissues. Mutations in the WNT5A gene are associated with Robinow Syndrome, a rare genetic disorder characterized by skeletal dysplasia, which includes short stature, limb abnormalities, genital hypoplasia, and distinctive facial features. Robinow Syndrome is classified into autosomal dominant and autosomal recessive types, with the autosomal dominant type 1 (AD1) being linked to mutations in the WNT5A gene.

To diagnose Robinow Syndrome AD1, a genetic test focusing on the WNT5A gene is available at DNA Labs UAE. This test is crucial for confirming the diagnosis, understanding the risk of passing the condition to offspring, and guiding management and treatment plans. The test involves analyzing the patient’s DNA to identify mutations in the WNT5A gene that are known to cause the condition.

The cost of the WNT5A Gene Robinow Syndrome Autosomal Dominant Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive test is conducted in a state-of-the-art facility, ensuring accurate and reliable results. By opting for this test, individuals suspected of having Robinow Syndrome or families with a history of the condition can gain valuable insights into their genetic makeup, facilitating informed decisions regarding health and family planning.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

WNT5A Gene Robinow Syndrome Autosomal Dominant Type 1 Genetic Test

Components

  • Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Dysmorphology

Doctor

Pediatrics

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for WNT5A Gene Robinow syndrome, autosomal dominant type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WNT5A Gene Robinow syndrome, autosomal dominant type 1 NGS Genetic DNA Test gene WNT5A

Test Details

The WNT5A gene is associated with Robinow syndrome, autosomal dominant type 1. This syndrome is a rare genetic disorder characterized by various physical abnormalities, including distinctive facial features, short stature, and skeletal abnormalities. NGS (Next-Generation Sequencing) genetic testing is a powerful tool used to analyze multiple genes simultaneously, allowing for a comprehensive evaluation of an individual’s genetic makeup.

In the context of Robinow syndrome, NGS testing can identify mutations or variations in the WNT5A gene that may be responsible for the condition. NGS testing involves extracting DNA from a blood or saliva sample and sequencing it to identify any alterations in the WNT5A gene. This type of testing can provide a definitive diagnosis and help determine the inheritance pattern of the condition. It can also assist in genetic counseling and family planning decisions.

It’s important to note that genetic testing should be conducted and interpreted by healthcare professionals experienced in genetics. They can provide appropriate counseling and guidance based on the test results.

Test Name WNT5A Gene Robinow syndrome autosomal dominant type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for WNT5A Gene Robinow syndrome, autosomal dominant type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WNT5A Gene Robinow syndrome, autosomal dominant type 1 NGS Genetic DNA Test gene WNT5A
Test Details

The WNT5A gene is associated with Robinow syndrome, autosomal dominant type 1. This syndrome is a rare genetic disorder characterized by various physical abnormalities, including distinctive facial features, short stature, and skeletal abnormalities.

NGS (Next-Generation Sequencing) genetic testing is a powerful tool used to analyze multiple genes simultaneously, allowing for a comprehensive evaluation of an individual’s genetic makeup. In the context of Robinow syndrome, NGS testing can identify mutations or variations in the WNT5A gene that may be responsible for the condition.

NGS testing involves extracting DNA from a blood or saliva sample and sequencing it to identify any alterations in the WNT5A gene. This type of testing can provide a definitive diagnosis and help determine the inheritance pattern of the condition. It can also assist in genetic counseling and family planning decisions.

It’s important to note that genetic testing should be conducted and interpreted by healthcare professionals experienced in genetics. They can provide appropriate counseling and guidance based on the test results.